Literature DB >> 33754484

Association of sigma-1 receptor with dopamine transporter attenuates the binding of methamphetamine via distinct helix-helix interactions.

Liang Xu1, Liao Y Chen1.   

Abstract

Dopamine transporter (DAT) and sigma-1 receptor (σ1R) are potential therapeutic targets to reduce the psychostimulant effects induced by methamphetamine (METH). Interaction of σ1R with DAT could modulate the binding of METH, but the molecular basis of the association of the two transmembrane proteins and how their interactions mediate the binding of METH to DAT or σ1R remain unclear. Here, we characterize the protein-ligand and protein-protein interactions at a molecular level by various theoretical approaches. The present results show that METH adopts a different binding pose in the binding pocket of σ1R and is more likely to act as an agonist. The relatively lower binding affinity of METH to σ1R supports the role of antagonists as inhibitors that protect against METH-induced effects. We demonstrate that σ1R could bind to Drosophila melanogaster DAT (dDAT) through interactions with either the transmembrane helix α12 or α5 of dDAT. Our results showed that the truncated σ1R displays stronger association with dDAT than the full-length σ1R. Although different helix-helix interactions between σ1R and dDAT lead to distinct effects on the dynamics of individual protein, both associations attenuate the binding affinity of METH to dDAT, particularly in the interactions with the helix α5 of dDAT. Together, the present study provides the first computational investigation on the molecular mechanism of coupling METH binding and the association of σ1R with dDAT.
© 2021 John Wiley & Sons A/S.

Entities:  

Keywords:  association; binding affinity; dopamine transporter; methamphetamine; sigma-1 receptor

Mesh:

Substances:

Year:  2021        PMID: 33754484      PMCID: PMC8113090          DOI: 10.1111/cbdd.13841

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.873


  64 in total

1.  Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models.

Authors:  P A Kollman; I Massova; C Reyes; B Kuhn; S Huo; L Chong; M Lee; T Lee; Y Duan; W Wang; O Donini; P Cieplak; J Srinivasan; D A Case; T E Cheatham
Journal:  Acc Chem Res       Date:  2000-12       Impact factor: 22.384

2.  Pharmacological profiling of sigma 1 receptor ligands by novel receptor homomer assays.

Authors:  Hideaki Yano; Alessandro Bonifazi; Min Xu; Daryl A Guthrie; Stephanie N Schneck; Ara M Abramyan; Andrew D Fant; W Conrad Hong; Amy H Newman; Lei Shi
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

3.  More bang for your buck: Improved use of GPU nodes for GROMACS 2018.

Authors:  Carsten Kutzner; Szilárd Páll; Martin Fechner; Ansgar Esztermann; Bert L de Groot; Helmut Grubmüller
Journal:  J Comput Chem       Date:  2019-07-01       Impact factor: 3.376

4.  Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; D Franceschi; M Sedler; S J Gatley; E Miller; R Hitzemann; Y S Ding; J Logan
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

Review 5.  Monoamine transporters: structure, intrinsic dynamics and allosteric regulation.

Authors:  Mary Hongying Cheng; Ivet Bahar
Journal:  Nat Struct Mol Biol       Date:  2019-07-03       Impact factor: 15.369

6.  Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types.

Authors:  Jeffery B Klauda; Richard M Venable; J Alfredo Freites; Joseph W O'Connor; Douglas J Tobias; Carlos Mondragon-Ramirez; Igor Vorobyov; Alexander D MacKerell; Richard W Pastor
Journal:  J Phys Chem B       Date:  2010-06-17       Impact factor: 2.991

7.  Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo.

Authors:  J Shawn Goodwin; Gaynor A Larson; Jarod Swant; Namita Sen; Jonathan A Javitch; Nancy R Zahniser; Louis J De Felice; Habibeh Khoshbouei
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

8.  Crystal structure of the human σ1 receptor.

Authors:  Hayden R Schmidt; Sanduo Zheng; Esin Gurpinar; Antoine Koehl; Aashish Manglik; Andrew C Kruse
Journal:  Nature       Date:  2016-04-04       Impact factor: 49.962

9.  Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice.

Authors:  Melissa A Tapia; John R Lever; Susan Z Lever; Matthew J Will; Eric S Park; Dennis K Miller
Journal:  Psychopharmacology (Berl)       Date:  2019-05-28       Impact factor: 4.530

10.  The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor.

Authors:  Ara M Abramyan; Hideaki Yano; Min Xu; Leanne Liu; Sett Naing; Andrew D Fant; Lei Shi
Journal:  Comput Struct Biotechnol J       Date:  2020-01-07       Impact factor: 7.271

View more
  2 in total

1.  Structural Insights into the Human Mitochondrial Pyruvate Carrier Complexes.

Authors:  Liang Xu; Clyde F Phelix; Liao Y Chen
Journal:  J Chem Inf Model       Date:  2021-10-19       Impact factor: 4.956

2.  Effects of the N-terminal dynamics on the conformational states of human dopamine transporter.

Authors:  Liang Xu; Liao Y Chen
Journal:  Biophys Chem       Date:  2022-01-25       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.